| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $37.40K | $26.59K | $22.95K | $16.62K | $31.62K |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | $1.52K |
| Operating Income | -$37.40K | -$26.59K | -$22.95K | $16.62K | $31.62K |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | $6.64K |
| Net Income | -$37.40K | -$26.59K | -$22.95K | -$16.62K | -$31.62K |
| EPS (basic) | -0.0100 | -0.0100 | -0.0100 | 0.0000 | -0.0100 |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |